ATIENTS harboring malignant neoplasms may develop neurological and endocrinological disorders in the absence of metastases to the nervous system or endocrine glands.1 The resulting clinical syndromes have been referred to as the "remote" or "nonmetastatic" effects of malignant tumors. The exact incidence of these complications has not been determined. Croft and Wilkinson2 state that nonmetastatic neurological syndromes develop in 2% to 16% of carcinomas, and of these, 65% are neuromuscular in type. The incidence of neurological involvement is highest with pulmonary malignancies. Although hypotheses implicating infectious, nutritional immunological, metabolic, and toxic factors have been suggested.1,3-7 the precise biological basis of these remote effects has not been determined.
We provide here a clinical and anatomical report of a man who presented with dementia, developed inappropriate secretion of the antidiuretic hormone (ADH), and died six months later in status epilepticus. General autopsy revealed a bronchogenic carcinoma which had not
Daniels AC, Chokroverty S, Barron KD. Thalamic Degeneration, Dementia, and Seizures: Inappropriate ADH Secretion Associated With Bronchogenic Carcinoma. Arch Neurol. 1969;21(1):15–24. doi:10.1001/archneur.1969.00480130029003
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: